Fundraising Fox

Morgan Hunter

Investor

Investment Manager at BioMedPartners

Zurich, Switzerland

About

Joined Biomed in 2022 with a background in scientific innovation and early entrepreneurship. Previously developed the business case for the ETH Zurich spin-off Emuna Therapeutics. Holds a Doctor of Sciences from ETH Zurich.

LinkedIn ↗

Experience

  1. BiomedVCInvestment Managercurrent2022 — presentBasel, Switzerland
  2. NXI Therapeutics AGBoard Observercurrent2026 — presentBasel, Switzerland
  3. OmnilinX TherapeuticsBoard Observercurrent2026 — presentMunich, Germany
  4. T-CURX GmbHBoard Observercurrent2025 — presentWürzburg, Germany
  5. iDEL Therapeutics GmbHBoard Observercurrent2025 — presentDortmund, Germany
  6. Salvina TherapeuticsBoard Observercurrent2024 — presentZürich, Switzerland
  7. Dimericon TherapeuticsBoard Observercurrent2023 — presentHorgen, Switzerland
  8. Venture KickJury Membercurrent2026 — presentSchlieren, Switzerland
  9. ETH ZürichEmuna Therapeutics: Innosuisse Innovation Project Leader & SNF BRIDGE Proof of Concept Fellow2019 — 2022Zurich, Switzerland
  10. ETH ZürichResearch Scientist: Doctoral & Postdoctoral Researcher2014 — 2019Zurich, Switzerland

Education

  1. ETH ZürichDoctor of Sciences (Dr. Sc. ETH Zurich)2014 — 2019
  2. Rhodes UniversityMaster of Science (MSc), Biochemistry2012 — 2013
  3. Rhodes UniversityBachelor of Science Honours (BSc Hons), Biotechnology2011
  4. Rhodes UniversityBachelor of Science (BSc), Biochemistry and Microbiology2008 — 2010

Skills & more

  • Financial Modeling & Valuation Analyst — Corporate Finance Institute
  • Innosuisse Business Creation Biotech — Venturelab

From Morgan's professional profile.

Same school

Also attended ETH Zürich136

Bastian HasslingerInvestor at Index VenturesSteve VassalloInvestor at Foundation CapitalHelge DaebelPartner, Head of Water at Emerald Technology Ventures AgMaurin DaiInvestment Manager, Physical AI & Robotics at Emerald Technology Ventures AgChristoph FreiPartner, Head of Energy at Emerald Technology Ventures AgMax HeftiInvestment Director - Energy at Emerald Technology Ventures Ag

+ 130 more

Also attended Rhodes University10

Tom NicholsonSenior Analyst at PeakBridge VCByron AndersonOperations / Finance at Standard CryptoBrendon GrunewaldGrowth – Data Sovereignity – Finance at AngelwiseLincoln WahlChief Financial Officer at FederationKristina McDougallAdvisor at RiSC Capital CorpMohamed CassimChief Investment Officer at Africa Climate Ventures

+ 4 more

Shared employers

Also worked at T-CURX GmbH1

Aristotelis NastosManaging Partner at BioMedPartners

Also worked at iDEL Therapeutics GmbH1

Aristotelis NastosManaging Partner at BioMedPartners

Also worked at ETH Zürich58

Max HeftiInvestment Director - Energy at Emerald Technology Ventures AgMichal NatoraSenior Investment Director - Industrial IT & Robotics at Emerald Technology Ventures AgAnnina WinklerSenior Investment Manager - Water & AgriFood at Emerald Technology Ventures AgAndreas GuggenbühlInvestor at Backbone VenturesJoel RoosInvestor at Backbone VenturesPaola BranniInvestor at Extantia Capital

+ 52 more

Colleagues at BioMedPartners

Aristotelis
Managing Partner at BioMedPartners
Aristotelis Nastos
Managing Partner at BioMedPartners
Claudia Ulbrich
Venture Partner at BioMedPartners
David Urech
Venture Partner at BioMedPartners
Dr. Aristotelis Nastos
Managing Partner at BioMedPartners
Dr. Claudia Ulbrich
Venture Partner at BioMedPartners
Dr. David Urech
Venture Partner at BioMedPartners
Dr. Marianna Feretzaki
Senior Associate at BioMedPartners